Literature DB >> 1696936

Evidence for diversity of Plasmodium falciparum sporozoite surface antigens derived from analysis of antibodies elicited in humans.

B Galey1, P Druilhe, I Ploton, C Desgranges, A Asavanich, T Harinasuta, C Marchand, K Brahimi, Y Charoenvit, C Paul.   

Abstract

We have compared the reactivities of antibodies developed by individuals frequently exposed to Plasmodium falciparum infections with the epitopes contained within the repeats of the circumsporozoite (CS) protein and their reactivities with the epitopes of a native molecule(s) accessible on the sporozoite surface. Results of direct-binding assays and competition assays between artificial and native molecules or between human antibodies and anti-CS monoclonal antibodies suggest that humans respond preferentially to epitopes not contained within the repeats of the CS protein and probably not contained in the whole CS protein. Human monoclonal antibodies reactive with P. falciparum sporozoite surface antigens were produced by Epstein-Barr virus transformation of human lymphocytes. Their pattern of reactivity with sporozoites from a number of different isolates indicates the existence of several distinct epitopes on the parasite surface. Differences between isolates and between sporozoites within a given sample were observed. No single human monoclonal antibody capable of detecting an epitope expressed in all the parasites studied was found.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696936      PMCID: PMC313601          DOI: 10.1128/iai.58.9.2995-3001.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  High affinity human monoclonal antibodies directed against hepatitis B surface antigen.

Authors:  C Desgranges; J Paire; C Pichoud; S Souche; D Frommel; C Trepo
Journal:  J Virol Methods       Date:  1987-07       Impact factor: 2.014

2.  Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum.

Authors:  W R Ballou; J Rothbard; R A Wirtz; D M Gordon; J S Williams; R W Gore; I Schneider; M R Hollingdale; R L Beaudoin; W L Maloy
Journal:  Science       Date:  1985-05-24       Impact factor: 47.728

3.  Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine.

Authors:  J F Young; W T Hockmeyer; M Gross; W R Ballou; R A Wirtz; J H Trosper; R L Beaudoin; M R Hollingdale; L H Miller; C L Diggs
Journal:  Science       Date:  1985-05-24       Impact factor: 47.728

4.  Levels of antibodies to Plasmodium falciparum sporozoite surface antigens reflect malaria transmission rates and are persistent in the absence of reinfection.

Authors:  P Druilhe; O Pradier; J P Marc; F Miltgen; D Mazier; G Parent
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

5.  Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine.

Authors:  W R Ballou; S L Hoffman; J A Sherwood; M R Hollingdale; F A Neva; W T Hockmeyer; D M Gordon; I Schneider; R A Wirtz; J F Young
Journal:  Lancet       Date:  1987-06-06       Impact factor: 79.321

6.  Differential non-responsiveness in humans of candidate Plasmodium falciparum vaccine antigens.

Authors:  I A Quakyi; L N Otoo; D Pombo; L Y Sugars; A Menon; A S De Groot; A Johnson; D Alling; L H Miller; M F Good
Journal:  Am J Trop Med Hyg       Date:  1989-08       Impact factor: 2.345

7.  Cloning of Plasmodium yoelii genes expressing three different sporozoite-specific antigens.

Authors:  A Wortman; P Rogers; Y Charoenvit; A McDermott; M Leef; M Sedegah; R L Beaudoin
Journal:  Microb Pathog       Date:  1989-03       Impact factor: 3.738

8.  Structure of the circumsporozoite protein gene in 18 strains of Plasmodium falciparum.

Authors:  J L Weber; W T Hockmeyer
Journal:  Mol Biochem Parasitol       Date:  1985-06       Impact factor: 1.759

9.  Ubiquity of the repetitive epitope of the CS protein in different isolates of human malaria parasites.

Authors:  F Zavala; A Masuda; P M Graves; V Nussenzweig; R S Nussenzweig
Journal:  J Immunol       Date:  1985-10       Impact factor: 5.422

10.  Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro.

Authors:  D Mazier; S Mellouk; R L Beaudoin; B Texier; P Druilhe; W Hockmeyer; J Trosper; C Paul; Y Charoenvit; J Young
Journal:  Science       Date:  1986-01-10       Impact factor: 47.728

View more
  2 in total

1.  How to select Plasmodium falciparum pre-erythrocytic antigens in an expression library without defined probe.

Authors:  C Marchand; P Druilhe
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  Immune responses and protection of Aotus monkeys immunized with irradiated Plasmodium vivax sporozoites.

Authors:  Alejandro Jordán-Villegas; Anilza Bonelo Perdomo; Judith E Epstein; Jesús López; Alejandro Castellanos; María R Manzano; Miguel A Hernández; Liliana Soto; Fabián Méndez; Thomas L Richie; Stephen L Hoffman; Myriam Arévalo-Herrera; Sócrates Herrera
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.